| AGA | Appropriate for gestational age |
| Akt | Protein kinase B |
| ARE | Antioxidant Response Element |
| COX-2 | Cyclooxygenase-2 |
| EGCG | Epigallocatechin-3-gallate |
| FGR | Fetal growth restriction |
| GD | Gestational day |
| GRAS | Generally recognized as a safe |
| GSH | Glutathion |
| HMGB1 | High mobility group box 1 |
| HO-1 | Heme oxygenase-1 |
| HUVECs | Human umbilical vein endothelial cells |
| LP | Low-protein |
| LPS | Lipopolysaccharides |
| MCP-1 | Monocyte chemoattractant protein-1 |
| MDA | Malondialdehyde |
| NF-κB | Nuclear Factor κB |
| NO | Nitric oxide |
| NRF2 | NFE2-related factor-2 |
| PE | Preeclampsia |
| PLGF | Placental growth factor |
| PPROM | Preterm premature rupture of membranes |
| PTB | Preterm birth |
| RCT | Randomized controlled trial |
| RESV | Resveratrol |
| ROS | Reactive oxygen species |
| RUPP | Reduced uterine perfusion pressure |
| SGA | Small for gestational age |
| SIRT-1 | Sirtuin-1 |
| sPTB | Spontaneous PTB |
| TGF-β | Transforming growth factor-beta |
| TLR4 | Toll Like Receptor 4 |
| TNF-α | Tumor necrosis factor-alpha. |
| WHO | World health organization |